Generic placeholder image

Current Drug Safety

Author(s): Wala B. Kridis, Afef Khanfir, Fatma Kammoun, Kheireddine B. Mahfoudh, Chahinez Triki and Mounir Frikha

DOI: 10.2174/1574886310666150518112823

DownloadDownload PDF Flyer Cite As
A Very Rare Cerebral Complication of Chemotherapy in a Young Girl: A Difficult Diagnosis

Page: [257 - 260] Pages: 4

  • * (Excluding Mailing and Handling)

Abstract

Sagittal sinus thrombosis (SST) induced by chemotherapy is exceptional. We describe here a new case following the fourth cure of chemotherapy based on cisplatin, bleomycin and etoposide in a 16-year-old patient with no obvious risk factors. Through this uncommon case which forms part of cerebral venous sinus thrombosis (CVST), we propose to study the pathophysiology, the diagnosis and the management of this entity.

The exclusion of the other causes of CVST is important not only for the therapeutic implication but also for the prognosis. Then, accurate documentation of each case induced by chemotherapy is needed to further understanding.

Keywords: Cerebral thrombosis, chemotherapy, cisplatin.

[1]
Kimber J. Cerebral venous sinus thrombosis. Q J Med 2002; 137-42.
[2]
Moore RA, Adel N, Riedel E, et al. High incidence of thromboembolic events in patients treated with Cisplatin-based chemotherapy: a large retrospective analysis. J Clin Oncol 2011; 29: 3466-73.
[3]
Unal E, Yazar A, Koksal Y, Caliskan U, Paksoy Y, Kalkan E. Cerebralvenous sinus thrombosis in an adolescent with Ewing sarcoma. Childs Nerv Syst 2008; 24: 983-6.
[4]
Li SH, Chen WH, Tang Y, et al. Incidence of ischemic stroke post-chemotherapy: a retrospective review of 10,963 patients. Clin Neurol Neurosurg 2006; 108(2): 150-6.
[5]
Goldhirsch A, Joss R, Markwalder TM, Studer H, Brunner K. Acute cerebrovascular accident after treatment with cis-platinum and methylprednisolone. Oncology 1983; 40: 344-5.
[6]
Seng S, Liu Z, Chiu SK, et al. Risk venous thromboembolism in patients with cancer treated with Cisplatin: a systematic review and meta-analysis. J Clin Oncol 2012; 30: 4416-26.
[7]
Karam C and , Koussa S. Cerebral dural sinus thrombosis following cisplatin chemotherapy. J Clin Neurosci 2008; 15: 1274-5.
[8]
Licciardello JT, Moake JL, Rudy CK, Karp DD, Hong WK. Elevated plasma von Willebrand factor levels and arterial occlusive complications associated with cisplatin-based chemotherapy. Oncology 1985; 42(5): 296-300.
[9]
Periard D, Boulanger CM, Eyer S, et al. Are circulating endothelialderived and platelet-derived microparticles a pathogenic factor in the cisplatin-induced stroke? Stroke 2007; 38(5): 1636-8.
[10]
Russmann S, Winkler A, Lovblad KO, Stanga Z, Bassetti C. Lethal ischemic stroke after cisplatin-based chemotherapy for testicular carcinoma and cannabis inhalation. Eur Neurol 2002; 7: 178-80.
[11]
De Bruin S, de Haan R, Stam J. Clinical features and prognostic factors of cerebral venous sinus thrombosis in a prospective series of 59 patients. J Neurol Neurosurg Psychiatry 2001; 70: 105-8.
[12]
Saposnik G, Barinagarrementeria F, Brown RD Jr, et al. Diagnosis and management of cerebral venous thrombosis: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2011; 1158-92.
[13]
Martinelli I, Franchini M, Mannucci PM. How I treat rare venous thromboses. Blood 2008; 4818-23.